WHO ICTRP trial
A clinical experimental study to evaluate the benefits and risks of PF-06865571…
CTRI/2020/10/028440 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2020/10/028440 |
|---|---|
| Public title | A clinical experimental study to evaluate the benefits and risks of PF-06865571 alone and when coadministered with PF-05221304 in patients with Non alcoholic hepatitis (NASH)and Fibrosis |
| Scientific title | A phase 2, randomized, double-blind, double-dummy, Placebo-controlled, dose-ranging, dose-finding, parallel group study to assess efficacy and safety of PF-06865571 (DGAT2i) alone and when coadministered with PF-05221304 (ACCi) in adult participants with biopsy-confirmed nonalcoholic Steatohepatitis… |
| Primary sponsor | Pfizer Inc |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | Bulgaria;Canada;China;Hong Kong;India;Japan;Other;Poland;Slovakia;Taiwan;United States of America;Republic of Korea |
| Conditions | Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified |
| Interventions | Intervention1: PF-06865571: Tablet Intervention2: Drug: PF-06865571 Tablet: (1)Experimental: PF-06865571 25 milligrams (mg) twice daily (BID) participants will receive medication for 48 weeks Intervention: Drug: PF-06865571 (2)Experimental… |
| Registration date | Oct 16, 2020 |
| Target size | 450 |
| Secondary IDs | 2019-004775-39;C2541013 (Final Protocol, dated 22/01/2020) |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: